Table 2 Unadjusted SVR rates among patients stratified by treatment choice and baseline HCV characteristics

Overall

215/309

69.6

64.5–74.7

158/215

73.5

67.6–79.4

57/94

60.6

50.7–70.5

Absence of cirrhosis

158/212

74.5

68.6–80.4

113/143

79

72.3–85.7

45/69

65.2

54–76.4

Presence of cirrhosis

48/79

60.8

47.8–69.2

36/55

65.5

52.9–78.1

12/24

50

30–70

Treatment naïve

153/217

70.5

64.4–76.6

109/146

74.7

67.6–81.8

44/71

56.5

36.2–76.4

Treatment experienced

61/89

68.5

58.8–78.2

48/66

72.7

62–83.4

13/23

62

50.7–73.3

Genotype 1a

115/172

66.9

59.9–73.9

84/119

70.6

62.4–78.8

31/53

58.5

45.2–71.8

Genotype 1b

64/86

74.4

65.2–83.6

46/55

83.6

78.8–93.4

18/31

58.1

40.7–70.5

Genotype 1 (no subtype)

35/49

71.4

58.7–84.1

27/39

69.2

54.7–83.7

8/10

80

55.2–104.8